Skip to main content
. 2018 Oct 28;8(10):e021632. doi: 10.1136/bmjopen-2018-021632

Table 2B.

Novel pathogenic sequence variations identified in IPN genes by next-generation sequencing

Patient Disease classification Inheritance Gene Haplotype cDNA change Amino acid change ACMG ExAC Mutation
Taster
Polyphen-2 UMD-Predictor PhyloP
1 CMT2 AR MFN2 GDAP1 het c.311G>A c.400delG p.Arg104Gln p.Asp134Metfs13 PP P NA NA D1 NA 1 PD NA 100 P NA 5,37 HC NA
5 CMT1 SPO INF2 het c.311G>A p.Cys104Tyr PP NA D1 NA NA 5,69 HC
7 CMT2 AD GAN het c.862C>G p.Pro288Ala PP NA D1 0,001 B NA 2,95 MC
13 HSAN AD SPTLC2 (HSPB3) het c.1304G>T (c.246_246delT) p.Gly435Val (p.Glu83Lysfs*13) PP VUS NA 5*10–5 D1 NA 1 PD NA 78 P NA 6,18 HC NA
14 CMT1 AR SH3TC2 comp.het c.[224G>C];
[3377T>C]
p.[Arg75Pro];
[Leu1126Pro]
PP/PP NA/NA D1/D1 1 PD/0999 PD 81 P/ 84 P 3,43 MC 4,81 HC
19 CMT2 AR GAN hoz c.890C>T p.Pro297Leu PP NA D1 0,906 Possibdam NA 5,86 HC
22 CMT2 AD AARS het c.525C>G p.Phe175Leu PP 1/121242 D1 1 PD 96 P 2,22 MC
24 CMT2 AR DARS2 comp.het c.[74_74delT(;)713C>T] p.[Ile25fs*38(;)
Ser238Phe]
P/VUS 2/
121358/NA
D1/NA 0,959 PD/NA 93 P/ NA 0,85 WC NA
26 CMT2 SPO MFN2 het c.1127T>G p.Met376Arg PP NA D1 0,984 PD 96 P 4,48 HC
29 CMT2 AD LRSAM1 het c.2138_2139delT p.Ile713Thrfs*22 P NA NA NA NA NA
30 HMN AR SPG11 comp.het c.[31G>C];
[6167A>T]
p.[Ala11Pro];
[Glu2056Val]
PP/VUS 6/121316 5/57750 D1/Poly 0,808 Possibdam 0,899 Possibdam 84 P/ 44 Poly 2,14 MC 0,04 WC
33 CMT2 AD KIF1B het c.2086C>G p.His696Asp PP NA D1 0,978 PD 81 P 5,61 HC
34 CMT SPO KIF1B het c.2030G>A p.Ser677Asn PP NA D1 1 PD 78 P 1,044 WC
36 CMT inter AD DNM2 het c.1352G>T p.Arg451Leu PP NA D1 NA 93 P 3,68 MC
37 CMT2 AD KIF5A het c.395A>G p.Lys132Arg PP NA D1 1 PD 78 P 1,088 WC
39 HMN AD REEP1 het c.568G>A p.Gly190Ser PP 3/119252 0,999 Poly 0,148 B 63ProbPoly 0,61 WC
40 CMT inter AD KIF5A het c.854C>T p.Thr285Ile PP NA D1 1 PD 93 P 5,29 HC
44 CMT2 AD KIF5A het c.332G>C p.Arg111Pro PP NA D1 1 PD 96 P 5,61 HC
45 CMT1 AD INF2 het c.314 T>G p.Val105Gly PP NA D1 1 PD 90 P 3,11 MC
46 CMT2 AR MFN2 comp.het c.[1714C>T];
[1928T>C]
p.[Gln572Glu];
[Leu643Pro]
PP/PP 1/246228
1/246238
D1/D1 0,073 B /
0,983 PD
100 P 100 P 5,13 HC 4,08 MC
48 HSAN AR FAM134B hoz c.896-897delAA p.Lys299Argfs*6 P 1/1 20 334 NA NA NA NA
55 HMN SPO DYNC1H1 het c.5578C>A p.Gln1860Lys PP NA D1 0,001 B 75 P 6,34 HC
57 HMN SPO MYH14 het c.4517G>T p.Arg1506Leu PP NA 0,929 D 0,987 PD 81 P 2,95 MC
58 CMT2 AD BICD2 het c.2042C>T p.Ser681Leu PP NA D1 1 PD 90 P 5,61 HC
59 CMT2 SPO SPTLC1 het c.451C>T p.Arg151Cys PP 2/118640 D1 0,264 B 100 P 4,00 MC
4 CMT2 AD NEFL het c.67C>G p.Arg23Gly VUS NA NA NA NA 2,09 WC
12 CMT1 AD LMNA het c.1694A>T p.His565Leu PP NA NA NA 84 P 2,30 MC
16 CMT1 AD GJB1 het c.830G>A p.Ser277Asn PB 2/26732 0,876 Poly 0,002 B 63 ProbPoly 2,38 MC
21 CMT1 AD TRPV4 KIF1B LRSAM1 het c.812G>A
c.3350A>G
c.1658A>C
p.Arg271His p.Tyr1117Cys p.Gln553Pro VUS VUS VUS 1/120838 1/120270 NA D1 Poly D1 0,764 Possibdam 0 B 0,994 PD 78 P NA 93 P 5,13 HC - 1,57 NC 3,60 MC
25 HSAN AD NEFL het c.995_997delAGC p.Gln332del P NA NA NA NA NA
27 CMT2 AD INF2 het c.2709G>C p.Gln903His VUS 1/119080 D 0,991 0,998 PD 57 ProbPoly 2,47 MC
35 CMT2 AD INF2 het c.3637C>T p.Arg1213Trp VUS 2/61282 Poly 0,998 PD 72 ProbPatho 1,66 WC
38 CMT2 SPO SEPT9 ARHGEF10 het c.53G>A c.3289A>G p.Arg18Thr p.Ile1097Val VUS VUS 1/118806 1/120124 Poly Poly 0,015 B 0,023 B 69 ProbPatho 66 ProbPatho 0,28 NC 0,04 WC
49 HSAN AD HSPB1 het c.224G>A p.Arg75His VUS NA D1 0,539 Possibdam 54 ProbPoly 2,38 MC
50 CMT inter AD YARS het c.710G>A p.Arg237Gln VUS 3/121190 0,983 D 0,018 B 78 P 2,47 MC
52 CMT inter AD INF2 het c.2459G>A p.Arg820Gln VUS NA Poly 0,001 B 39 Poly −0,68 NC
61 CMT1 SPO FGD4 Duplication of exons 3 to 14 Not described in conrad.hg19
62 CMT2 AR TFG Duplication of exons 2 and 3 Not described in conrad.hg19
28 CMT2 AD TFG Sequence variation in
LITAF and DCTN1
+duplication of exons 2 and 3
Not described in conrad.hg19

AD, autosomal dominant; AR, autosomal recessive; B, benign; CMT1, Charcot-Marie-Tooth disease type 1; CMT2, Charcot-Marie-Tooth disease type 2; comp het, compound heterozygous; comp het, composite heterozygosis; D1, disease causing; HC, highly conserved; het, heterozygous; hoz, homozygous; HSAN, hereditary sensory and autonomic neuropathy; IPN, inherited peripheral neuropathy; MC, moderately conserved; NA, not available; NT, not conserved; P, pathogenic; Poly, polymorphism; Possibdam, possibly damaging; PB, probably benign; PD, probably damaging; PP, probably pathogenic; ProbPoly, probably polymorphism; ProbPatho, probably pathogenic; SPO, sporadic; VUS, variant of unknown significance; WC, weakly conserved.